862816-19-1

Basic information

• Product Name: Pyrido[2,3-d]pyridazin-8(7H)-one, 5-(4-methoxyphenyl)-
• CAS NO: 862816-19-1
• Molecular Formula: C14H11N3O2
• Molecular Weight: 253.26
• Mol File: 862816-19-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Pyrido[2,3-d]pyridazin-8(7H)-one, 5-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyrido[2,3-d]pyridazin-8(7H)-one, 5-(4-methoxyphenyl)-(862816-19-1)
• EPA Substance Registry System: Pyrido[2,3-d]pyridazin-8(7H)-one, 5-(4-methoxyphenyl)-(862816-19-1)

Safety Data

• Hazardous Substances Data: 862816-19-1(Hazardous Substances Data)

Upstream product

• 116060-92-5 3-(4-methoxybenzoyl)-pyridine-2-carboxylic acid 
• 164463-15-4 2-(4-methoxyphenylcarbonyl)-3-pyridine carboxylic acid 
• 100-66-3 methoxybenzene 
• 699-98-9 Pyridine-2,3-dicarboxylic anhydride 
• 874947-48-5 5-(4-methoxy-phenyl)-pyrido[3,2-d][1,2]oxazin-8-one 

Downstream Products

• 862816-20-4 5-chloro-8-(4-methoxyphenyl)-pyrido[2,3-d]pyridazine 
• 862816-21-5 8-chloro-5-(4-methoxyphenyl)-pyrido[2,3-d]pyridazine 

Relevant articles and documents

NITROGENOUS FUSED HETEROAROMATIC RING DERIVATIVE

The invention provides a compound or its pharmaceutically-acceptable salt of formula (I): wherein A1 is a hydrogen, etc.; j and k are 0 or 1; is a double bond, etc.; is a double bond, etc.; one of W1 and W2 is E-O-W, etc., and the other is a hydrogen atom, etc.; E is a divalent group derived from a benzene ring, etc., by removing two hydrogen atoms therefrom; W is a group of formula (II-1): which has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for prevention or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.

Benzopyridazinone and pyridopyridazinone compounds

Benzo or pyridopyridazinones and pyridazinthiones of the formula STR1 wherein: X and Y are nitrogen or carbon, provided that at least one is carbon, and Z is oxygen or sulfur; R1 is hydrogen, lower alkyl, aryl, aralkyl, heterocyclo, heterocyclo lower-alkyl, heteroaryl, or heteroaralkyl; R2, R3, R4, R5 and R6 are independently selected from hydrogen, lower alkyl, halo, carboxy, alkoxycarbonyl, carbamoyl, lower-alkyl carbonyl, halocarbonyl, thiomethyl, trifluoromethyl, cyano or nitro; or a pharmaceutically acceptable ester, ether or salt thereof, have been found to be useful as an anti-inflammatory, antasthmatic, immunosuppressive, anti-allograft rejection, anti-graft-vs-host rejection, autoimmune disease or analgetic agent(s).